Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LEGN

Legend Biotech (LEGN)

Legend Biotech Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LEGN
DateTimeSourceHeadlineSymbolCompany
12/14/20208:00AMBusiness WireLegend Biotech Announces FDA Clearance of the IND for LB1901, an Investigational Autologous Anti-CD4 CAR-T Therapy for Relaps...NASDAQ:LEGNLegend Biotech Corporation
12/05/20203:00PMBusiness WireLegend Biotech Announces Phase 1b/2 Study Data of Cilta-cel, an Investigational BCMA CAR-T, Showing Early, Deep, & Durable Re...NASDAQ:LEGNLegend Biotech Corporation
12/03/20208:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LEGNLegend Biotech Corporation
12/03/20208:00AMBusiness WireLegend Biotech Announces Appointment of Dr. Patrick Casey to the Board of DirectorsNASDAQ:LEGNLegend Biotech Corporation
11/24/20208:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LEGNLegend Biotech Corporation
11/24/20208:00AMBusiness WireLegend Biotech to Host Virtual Investor KOL Event Reviewing Latest CARTITUDE-1 Data from the 62nd American Society of Hematol...NASDAQ:LEGNLegend Biotech Corporation
11/23/20207:20AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LEGNLegend Biotech Corporation
11/23/20207:00AMBusiness WireLegend Biotech Announces New Appointment to the Board of Directors and Resignation of Dr. Fangliang ZhangNASDAQ:LEGNLegend Biotech Corporation
11/16/20207:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LEGNLegend Biotech Corporation
11/16/20207:00AMBusiness WireLegend Biotech Reports Third Quarter 2020 Financial ResultsNASDAQ:LEGNLegend Biotech Corporation
11/09/202011:06AMBusiness WireLegend Biotech Announces Leadership TransitionNASDAQ:LEGNLegend Biotech Corporation
11/09/20208:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LEGNLegend Biotech Corporation
11/09/20208:05AMBusiness WireLegend Biotech Announces Leadership TransitionNASDAQ:LEGNLegend Biotech Corporation
11/05/20207:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LEGNLegend Biotech Corporation
11/05/20207:05AMBusiness WireLegend Biotech Announces ASH 2020 Data Presentations for Ciltacabtagene Autoleucel (cilta-cel), an Investigational BCMA CAR-T...NASDAQ:LEGNLegend Biotech Corporation
09/28/20204:30PMBusiness WireLegend Biotech to Participate in the Jefferies Virtual Cell Therapy SummitNASDAQ:LEGNLegend Biotech Corporation
09/21/20207:37AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:LEGNLegend Biotech Corporation
09/21/20206:30AMBusiness WireLegend Biotech Names Current Chief Financial Officer, Ying Huang, as Interim CEONASDAQ:LEGNLegend Biotech Corporation
09/04/20204:20PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LEGNLegend Biotech Corporation
09/01/20204:00PMBusiness WireLegend Biotech to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare ConferenceNASDAQ:LEGNLegend Biotech Corporation
08/28/20204:34PMBusiness WireLegend Biotech Reports Second Quarter 2020 Financial ResultsNASDAQ:LEGNLegend Biotech Corporation
08/05/20205:37PMBusiness WireThe China Center for Drug Evaluation, National Medical Products Administration Has Recommended Breakthrough Therapy Designati...NASDAQ:LEGNLegend Biotech Corporation
08/03/20206:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:LEGNLegend Biotech Corporation
08/02/202011:02AMBusiness WireLegend Biotech Announces Chief Executive Officer TransitionNASDAQ:LEGNLegend Biotech Corporation
08/02/202010:43AMBusiness WireLegend Biotech Announces Preliminary Results for First Half of 2020NASDAQ:LEGNLegend Biotech Corporation
07/16/20208:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:LEGNLegend Biotech Corporation
06/26/20204:12PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:LEGNLegend Biotech Corporation
06/09/20204:35PMBusiness WireLegend Biotech Announces Three New Appointments to the Board of DirectorsNASDAQ:LEGNLegend Biotech Corporation
06/09/20204:30PMBusiness WireLegend Biotech Corporation Announces Closing of Initial Public OfferingNASDAQ:LEGNLegend Biotech Corporation
 Showing the most relevant articles for your search:NASDAQ:LEGN